Method for predicting the response to treatment with radiotherapy combined with chemotherapy based on cisplatin

Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/243098

COMPARTIR / EXPORTAR:

SHARE BASE	Comparte tu historia de Acceso Abierto
Visualizar otros formatos: MARC \| Dublin Core \| RDF \| ORE \| MODS \| METS \| DIDL \| DATACITE
Refman EndNote Bibtex RefWorks Excel CSV PDF DataCite Send via email

Título:	Method for predicting the response to treatment with radiotherapy combined with chemotherapy based on cisplatin
Autor:	Ibáñez de Cáceres, Inmaculada CSIC ORCID; Belda-Iniesta, Cristobal; Pernía, Olga CSIC; Perona Abellón, Rosario CSIC ORCID; Cortés-Sempere, María CSIC
Fecha de publicación:	5-may-2016
Citación:	US2016/0122828 A1
Resumen:	The invention relates to a method to predict the response to treatment with radiotherapy combined with cisplatin-based chemotherapy in patients with cancer, preferably non-microcytic lung cancer, wherein said method is based on the detection of the presence of methylation in the IGFBP-3 gene. The present invention also relates to an in vitro method to design a customised treatment for an individual with said disease. The method of the invention may be quantitative or semi-quantitative. The present invention also relates to a probe designed for the quantitative detection of the methylation of the IGFBP-3 gene, to a kit that comprises it and to the use of the kit to predict the response of a subject to the aforementioned treatment
URI:	http://hdl.handle.net/10261/243098
Aparece en las colecciones:	(IIBM) Patentes